119-hr5592

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5592 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 5592

 To prohibit the performance of gender-related medical treatment on 
 minors, to amend title XVIII of the Social Security Act to prohibit 
 payment and participation under the Medicare program with respect to 
 such treatment, and for other purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 September 26, 2025

 Ms. Mace (for herself, Mr. Burchett, Mr. Weber of Texas, and Ms. 
 Boebert) introduced the following bill; which was referred to the 
Committee on Energy and Commerce, and in addition to the Committees on 
 the Judiciary, and Ways and Means, for a period to be subsequently 
 determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

 A BILL

 To prohibit the performance of gender-related medical treatment on 
 minors, to amend title XVIII of the Social Security Act to prohibit 
 payment and participation under the Medicare program with respect to 
 such treatment, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Childhood Genital Mutilation 
Prevention Act''.

SEC. 2. PROHIBITING GENDER-RELATED MEDICAL TREATMENT FOR MINORS.

    (a) In General.--Chapter 7 of title 18, United States Code, is 
amended by inserting after 

section 116 the following new section:
``

Sec. 116A. Gender-related medical treatment furnished to minors.
 ``

    (a) In General.--Subject to subsection
            (c) , whoever, in a 
circumstance described in subsection

    (b) , knowingly performs or 
attempts to perform a gender-related medical treatment on a minor, 
shall be fined under this title, imprisoned not more than 10 years, or 
both.
 ``

    (b) Circumstances Described.--For the purposes of subsection

    (a) , 
the circumstances described in this subsection are that--
 ``

    (1) the offender or victim traveled in interstate or 
 foreign commerce, or traveled using a means, channel, facility, 
 or instrumentality of interstate or foreign commerce, in 
 furtherance of or in connection with the conduct described in 
 subsection

    (a) ;
 ``

    (2) the offender used a means, channel, facility, or 
 instrumentality of interstate or foreign commerce in 
 furtherance of or in connection with the conduct described in 
 subsection

    (a) ;
 ``

    (3) any payment of any kind was made, directly or 
 indirectly, in furtherance of or in connection with the conduct 
 described in subsection

    (a) using any means, channel, facility, 
 or instrumentality of interstate or foreign commerce or in or 
 affecting interstate or foreign commerce;
 ``

    (4) the offender transmitted in interstate or foreign 
 commerce any communication relating to or in furtherance of the 
 conduct described in subsection

    (a) using any means, channel, 
 facility, or instrumentality of interstate or foreign commerce 
 or in or affecting interstate or foreign commerce by any means 
 or in manner, including by computer, mail, wire, or 
 electromagnetic transmission;
 ``

    (5) any instrument, item, substance, or other object that 
 has traveled in interstate or foreign commerce was used to 
 perform the conduct described in subsection

    (a) ;
 ``

    (6) the conduct described in subsection

    (a) occurred 
 within the special maritime and territorial jurisdiction of the 
 United States, or any territory or possession of the United 
 States; or
 ``

    (7) the conduct described in subsection

    (a) otherwise 
 occurred in or affected interstate or foreign commerce.
 ``
            (c) Exceptions.--
 ``

    (1) In general.--An individual who provides gender-
 related medical treatment to a minor shall not be considered to 
 have violated the prohibition in subsection

    (a) if such medical 
 treatment is provided to such minor for purposes of treating--
 ``
        (A) a disorder of sex development, diagnosed by a 
 physician after such physician has determined through 
 genetic or biochemical testing that such minor does not 
 have normal sex chromosome structure, sex steroid 
 hormone production, or sex steroid hormone action;
 ``
        (B) irresolvably ambiguous biological sex 
 characteristics of such minor, including the presence 
 of--
 ``
            (i) 46 XX chromosomes with virilization;
 ``
            (ii) 46 XY chromosomes with 
 undervirilization; or
 ``
            (iii) both ovarian and testicular tissue; 
 or
 ``
            (C) an infection, injury, disease, or disorder 
 caused or exacerbated by gender-related medical 
 treatment that was furnished to such minor.
 ``

    (2) Exception for minors.--A minor who seeks gender-
 related medical treatment, or on whom gender-related medical 
 treatment was performed, shall not be considered to have 
 violated the prohibition in subsection

    (a) .
 ``
            (d) === Definitions. ===
-In this section:
 ``

    (1) Gender-related medical treatment.--The term `gender-
 related medical treatment' means--
 ``
        (A) with respect to a female individual, medical 
 treatments provided for purposes of addressing the 
 perception of such individual that the gender or sex of 
 such individual is not female, including--
 ``
            (i) surgical procedures, including--
 ``
            (I) vaginectomy;
 ``
            (II) hysterectomy;
 ``
            (III) oophorectomy;
 ``
            (IV) reconstruction of the 
 urethra;
 ``
            (V) metoidioplasty;
 ``
            (VI) phalloplasty;
 ``
            (VII) salpingo-oophorectomy;
 ``
            (VIII) scrotoplasty;
 ``
            (IX) implantation of erection or 
 testicular protheses;
 ``
            (X) subcutaneous mastectomy;
 ``
            (XI) vocal cord surgery;
 ``
            (XII) pectoral implants; and
 ``
            (XIII) penile transplantation;
 ``
            (ii) exogenous doses of testosterone or 
 other androgens; and
 ``
            (iii) puberty blockers, including--
 ``
            (I) GnRH agonists; and
 ``
            (II) synthetic drugs that 
 suppress the production of estrogen and 
 progesterone or delay or suppress 
 pubertal development in female 
 individuals; and
 ``
        (B) with respect to a male individual, medical 
 treatments provided for purposes of addressing the 
 perception of such individual that the gender or sex of 
 such individual is not male, including--
 ``
            (i) surgical procedures, including--
 ``
            (I) penectomy;
 ``
            (II) orchiectomy;
 ``
            (III) vaginoplasty;
 ``
            (IV) clitoroplasty;
 ``
            (V) vulvoplasty;
 ``
            (VI) augmentation mammoplasty;
 ``
            (VII) facial feminization 
 surgery;
 ``
            (VIII) vocal cord surgery;
 ``
            (IX) chondrolaryngoplasty;
 ``
            (X) gluteal augmentation; and
 ``
            (XI) uterine transplantation;
 ``
            (ii) exogenous doses of estrogen; and
 ``
            (iii) puberty blockers, including--
 ``
            (I) GnRH agonists; and
 ``
            (II) synthetic drugs that 
 suppress the production of testosterone 
 or delay or suppress pubertal 
 development in male individuals.
 ``

    (2) Female.--The term `female' means an individual who 
 naturally has, had, will have, or would have, but for a 
 developmental or genetic anomaly or historical accident, the 
 reproductive system that at some point produces, transports, 
 and utilizes eggs for fertilization.
 ``

    (3) Gender.--The term `gender'--
 ``
        (A) means--
 ``
            (i) males, females, or the natural 
 differences between males and females, unless 
 such term is otherwise specified or used alone, 
 rather than with or as an adjective modifying 
 other words; and
 ``
            (ii) a synonym for sex; and
 ``
        (B) does not mean gender identity, experienced 
 gender, gender expression, or gender roles.
 ``

    (4) Male.--The term `male' means an individual who 
 naturally has, had, will have, or would have, but for a 
 developmental or genetic anomaly or historical accident, the 
 reproductive system that at some point produces, transports, 
 and utilizes sperm for fertilization.
 ``

    (5) Minor.--The term `minor' means an individual under 18 
 years of age.
 ``

    (6) Sex.--The term `sex' means the biological 
 determination as to whether an individual is male or female.''.

    (b) Clerical Amendment.--The table of sections for such chapter is 
amended by inserting after the item relating to 

section 116 the 
following new item:

``116A. Gender-related medical treatment for minors.''.

SEC. 3. PROHIBITING PAYMENT AND PARTICIPATION UNDER MEDICARE WITH 
 RESPECT TO GENDER-RELATED MEDICAL TREATMENT FOR MINORS.

    (a) Excluding From Coverage Gender-Related Medical Treatment for 
Minors.--

Section 1862

    (a) of the Social Security Act (42 U.S.C. 
1395y

    (a) ) is amended--

    (1) in paragraph

    (24) , by striking ``or'' at the end;

    (2) in paragraph

    (25) , by striking the period at the end 
 and inserting ``; or''; and

    (3) by inserting after paragraph

    (25) the following new 
 paragraph:
 ``

    (26) beginning on the date that is 90 days after the date 
 of the enactment of the Childhood Genital Mutilation Prevention 
 Act, which constitute gender-related medical treatment for 
 minors described in 

section 116A of chapter 7 of title 18, 
 United States Code, and are not provided for the purposes 
 described in subsection
            (c) (1) of such section.''.

    (b) Excluding From Participation Providers Furnishing Gender-
Related Medical Treatment for Minors.--

Section 1866 of the Social 
Security Act (42 U.S.C. 1395cc) is amended by adding at the end the 
following new subsection:
 ``
            (l) Exclusion of Providers Furnishing Gender-Related Medical 
Treatment for Minors.--Beginning on the date that is 90 days after the 
date of the enactment of the Childhood Genital Mutilation Prevention 
Act, with respect to a provider of services or supplier that, on or 
after the date that is 90 days after such date of enactment, furnishes 
gender-related medical treatment for minors, as described in 

section 116A of chapter 7 of title 18, United States Code to any individual 
(other than such a treatment that is furnished for the purposes 
described in subsection
            (c) (1) of such section), regardless of whether 
such individual is entitled to benefits under part A or enrolled under 
part B--
 ``

    (1) if such provider of services or supplier is enrolled 
 in the program under this title, the Secretary shall terminate 
 such enrollment; and
 ``

    (2) the Secretary may not enroll such provider of 
 services or supplier as a new provider of services or supplier 
 in the program under this title.''.

SEC. 4. PROHIBITION ON FEDERAL FUNDING FOR GENDER-RELATED MEDICAL 
 TREATMENT FOR MINORS.

 No funds authorized or appropriated by Federal law, and none of the 
funds in any trust fund to which funds are authorized or appropriated 
by Federal law, shall be obligated or expended for any gender-related 
medical treatment furnished to a minor (as such terms are used for 
purposes of 

section 116A of chapter 7 of title 18, United States Code) 
or for any health benefits coverage that includes coverage for gender-
related medical treatment furnished to a minor.
 <all>